Pauls Dietrich John - Insider Non-Derivative Transactions at DiaMedica Therapeutics Inc. (DMAC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 23, 2023, Pauls Dietrich John's relationship to DiaMedica Therapeutics Inc. (DMAC) is Director,Officer (President and CEO), and currently has 68,591 shares of Voting Common Shares, no par value per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DMAC insiders.
Data Source: SEC.
Pauls Dietrich John - Insider Non-Derivative Transactions at DMAC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 24, 2023 | P -- (Voting Common Shares, no par value per share) | 12787 | 3.91 | 68591 |